Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.3, and our video podcast, CANCER BUZZ TV.

TxSCO is raising its advocacy voice on state and federal issues.

We are actively working to ensure that the voice of oncology in Texas is heard. Explore our website for the latest updates in oncology and healthcare-related legislation in Texas, discover TxSCO's advocacy on the state and federal level, and more. 

TxSCO values your input. Help us make a difference in our state. Do you know a Texas State Legislature member? Do you have an issue you want to bring attention to? Please send all questions and comments to Nicole Rodin, Executive Director.

State Advocacy

TxSCO Joins ASCO in Support Letter for HB 293

The Texas Society of Clinical Oncology (TxSCO) and the Association for Clinical Oncology (ASCO) are pleased to support House Bill 293: Relating to health benefit coverage for certain fertility preservation services under certain health benefit plans, which would provide coverage for fertility preservation services for patients with cancer when necessary medical treatments may cause infertility. The House Insurance Committee’s passage of HB 293 would be a crucial step in helping to make Texas the 11th state to provide this important protection for patients with cancer. Read support letter

Posted 03/18/2021


Federal Advocacy

Federal and State Advocacy Updates—June 2021
  • Federal
    • Infrastructure/Drug Pricing
      • Latest Intel; only one partisan attempt at legislation remains for 2021
    • Biden Administration
      • FY 2022 Budget
      • CMMI: Ready to act if Congress fails, supports past efforts on International Reference Pricing
    • Medicaid Proposed Rule
      • Value-Based Purchasing flexibilities delayed six months, coupon policy remains in place
  • State
    • 87th Session Overview
    • Leadership Priorities and Bills of Note
    • Budget Update

View Full Report

Federal and State Advocacy Updates—May 2021
  • Federal
    • Biden/Congress
      • Looking Back: Biden’s First 100 Days
      • Looking Forward: Biden’s Plan Omits Drug Pricing, Congressional Democrats Push Back
      • Drug Pricing Reforms: Likelihood of Enactment?
      • Legislative Issues by Payer & TxSCO Impact
    • Notable Reports
      • AMA: 40% of Physicians are Employed by Hospitals
      • AMA: Medicare Physician Spending has Increased, But Still Down 8% in Q3 2020
    • Appendix
      • Providers Advocate to Reinstate Medicare Advantage Step Therapy Prohibition
      • Implementation of H.R. 3 Government Negotiation: Hypothetical Timeline
      • Biden Admin. Supports Waiving COVID Vaccine Patents
  • State
    • Legislative Updates
    • State Budget Updates

View Full Report


Update for MIPS-Eligible Clinicians Affected by Extreme Circumstances

In response to the Federal Emergency Management Agency (FEMA) designation of the Texas Severe Winter Storm as a national disaster, the Centers for Medicare & Medicaid Services has determined that the automatic extreme and uncontrollable circumstances policy will apply to Merit-based Incentive Payment System (MIPS) eligible clinicians in FEMA-identified Texas areas.

MIPS-eligible clinicians in these areas will be automatically identified and receive a neutral payment adjustment for the 2023 MIPS payment year. During the data submission period for the 2021 performance period (January 3, 2022 to March 31, 2022), all four performance categories for these clinicians will be weighted at zero percent, resulting in a score equal to the performance threshold. Click here for more information.

Posted 05/13/2021


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
Email Us